Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07439-ySource: DataRank Database

Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression is a research paper published in Breast Cancer Research and Treatment (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.40)OA: closedTopics (63)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Rima Patel ORCID,Emily J. Gallagher ORCID,Tianxiang Sheng ORCID,Damodara Rao Mendu ORCID,Amy Tiersten ORCID

Live enrichment

PubMed:39110275 OpenAlex:https://openalex.org/W4401391591

National Institutes of Health

Grant: R37CA266853

National Institutes of Health

Grant: 5UG1CA189859

National Institutes of Health

Grant: 5UG1CA189859-03

Minority-Based Community Oncology Research Program

National Institutes of Health

Grant: 1R37CA266853-01A1

Understanding how elevated triglycerides contribute to triple negative breast cancer growth and metastasis

National Institutes of Health

Grant: 3UM1CA121947-19S9

Consortium for Advancing Management and Prevention of Cancer in People with HIV

Pfizer

Novartis Pharmaceuticals Corporation

Breast Cancer Research Foundation

Eli Lilly and Company

Susan G. Komen for the Cure

V Foundation

FWCI

1.40

Citation Percentile

0.8%

Citation Trend

2025

2026

closedLicense: Springer Nature TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-024-07439-y.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-024-07439-y/fulltext.html

journalhttps://doi.org/10.1007/s10549-024-07439-y

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39110275

Fields of Study

Advanced Breast Cancer TherapiesEstrogen and related hormone effectsCancer-related Molecular PathwaysHumansFemaleEstradiolPremenopauseBreast NeoplasmsAdultRetrospective StudiesBenzimidazolesMiddle AgedTandem Mass SpectrometryAminopyridinesChromatography, LiquidAromatase InhibitorsChemotherapy, AdjuvantOvary

MeSH Terms

AdultAminopyridinesBenzimidazolesBreast NeoplasmsChromatography, LiquidEstradiolFemaleHumansMiddle AgedOvaryRetrospective StudiesChemotherapy, AdjuvantPremenopauseAromatase InhibitorsTandem Mass Spectrometry

Keywords

MedicineTamoxifenBreast cancerInternal medicineOncologyGynecologyOophorectomyEstrogenPopulationCancerHysterectomySurgeryPremenopausalAbemaciclibOvarian Function SuppressionAdultEstradiolAromatase InhibitorsOvaryAminopyridinesBreast NeoplasmsMiddle AgedPremenopauseTandem Mass SpectrometryChemotherapy, AdjuvantHumansFemaleBenzimidazolesRetrospective StudiesChromatography, Liquid

Sustainable Development Goals

SDG 0: Gender equality

Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression

FAIR Checklist

Authors (12)

Funding (11 grants)

Impact

Open Access

Topics